Additionally, chemokines like MCP-1 and receptors including CX3CR1 and CCR3 are implicated in tau phosphorylation, further advancing AD pathology (Wang et al., 2023, Kim et al., 2008). This evidence concerns the gene MAPT and Alzheimer disease.